{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:27:32Z","timestamp":1784309252492,"version":"3.55.0"},"reference-count":30,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.14745\/ccdr.v44i02a01","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T18:54:54Z","timestamp":1518461694000},"page":"37-42","source":"Crossref","is-referenced-by-count":38,"title":["Gonorrhea in Canada, 2010\u20132015"],"prefix":"10.14745","volume":"44","author":[{"given":"Y","family":"Choudhri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Aho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5795","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"12","key":"key20180212135453_r1","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key20180212135453_r2"},{"key":"key20180212135453_r3","unstructured":"Centers for Disease Control and Prevention. Gonorrhea \u2013 CDC fact sheet (detailed version). Atlanta (GA): CDC; 2016 Oct. https:\/\/www.cdc.gov\/std\/gonorrhea\/stdfact-gonorrhea-detailed.htm"},{"key":"key20180212135453_r4"},{"issue":"1","key":"key20180212135453_r5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrmicro794","article-title":"The role of sexually transmitted diseases in HIV transmission","volume":"2","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"key20180212135453_r6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ddmec.2007.12.003","article-title":"More than their sum in your parts: the mechanisms that underpin the mutually advantageous relationship between HIV and sexually transmitted infections","volume":"4","year":"2007","journal-title":"Drug Discov Today Dis Mech"},{"issue":"2","key":"key20180212135453_r7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.14745\/ccdr.v41i02a02","article-title":"Gonorrhea in Canada: 2003-2012","volume":"41","year":"2015","journal-title":"Can Commun Dis Rep"},{"issue":"2","key":"key20180212135453_r8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14745\/ccdr.v41i02a04","article-title":"Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009-2013","volume":"41","year":"2015","journal-title":"Can Commun Dis Rep"},{"key":"key20180212135453_r9","unstructured":"Public Health Agency of Canada. Canadian antimicrobial resistance surveillance system \u2013 report 2016. Ottawa (ON): PHAC; 2016 Sep. https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/drugs-health-products\/antibiotic-resistance-antibiotique\/antibiotic-resistance-antibiotique-2016-eng.pdf"},{"key":"key20180212135453_r10","unstructured":"Public Health Agency of Canada. Canadian Notifiable Disease Surveillance System national report: 2005-2008. Ottawa (ON): PHAC; 2012. http:\/\/publications.gc.ca\/collections\/collection_2012\/aspc-phac\/HP40-75-2012-eng.pdf"},{"key":"key20180212135453_r11","first-page":"S1","article-title":"Case definitions for communicable diseases under national surveillance; results of provincial\/territorial (P\/T) consultation process","volume":"35","author":"Public Health Agency of Canada","year":"2009","journal-title":"Can Commun Dis Rep"},{"key":"key20180212135453_r12","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2016. Atlanta (GA): US Department of Health and Human Services; 2017. https:\/\/www.cdc.gov\/std\/stats16\/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf"},{"key":"key20180212135453_r13","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2015. Atlanta (GA): US Department of Health and Human Services; 2016. https:\/\/www.cdc.gov\/std\/stats15\/STD-Surveillance-2015-print.pdf"},{"key":"key20180212135453_r14","unstructured":"The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2016. Sydney (AU): University of New South Wales; 2016. https:\/\/kirby.unsw.edu.au\/sites\/default\/files\/kirby\/report\/SERP_Annual-Surveillance-Report-2016_UPD170627.pdf"},{"key":"key20180212135453_r15","unstructured":"Public Health England. Table 2: New diagnoses & rates by gender, sexual risk & age group, 2012-2016. London (UK): Public Health England; https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/626361\/2016_Table_2_Selected_STI_diagnoses___rates_by_gender__sexual_risk___age_group.pdf"},{"issue":"2","key":"key20180212135453_r16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/OLQ.0000000000000553","article-title":"Increased detection of pharyngeal and rectal gonorrhea in men who have sex with men after transition from culture to nucleic acid amplification testing","volume":"44","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"9","key":"key20180212135453_r17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.olq.0000431356.80840.d4","article-title":"Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada","volume":"40","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key20180212135453_r18","unstructured":"Public Health Agency of Canada. Treatment of N. gonorrhoeae in response to the discontinuation of spectinomycin: alternative treatment guidance statement. Ottawa (ON): PHAC; 2017. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/gonorrhea-alternate-treatment.html"},{"issue":"5 Pt 1","key":"key20180212135453_r19","first-page":"321","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010","volume":"158","year":"2013","journal-title":"Ann Intern Med"},{"issue":"8","key":"key20180212135453_r20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/sextrans-2017-053224","article-title":"The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis","volume":"93","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"7","key":"key20180212135453_r21","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/JCM.00493-15","article-title":"Molecular assay for detection of genetic markers associated with decreased susceptibility to cephalosporins in Neisseria gonorrhoeae","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"1","key":"key20180212135453_r22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/sextrans-2015-052422","article-title":"Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing","volume":"93","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"10","key":"key20180212135453_r23","first-page":"435","article-title":"Recent trends in chlamydia and gonorrhea in British Columbia","volume":"51","year":"2009","journal-title":"BCMJ"},{"issue":"7","key":"key20180212135453_r24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007435-200307000-00006","article-title":"Increases in gonorrhea and sexual risk behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health Clinic","volume":"30","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"4","key":"key20180212135453_r25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11904-013-0188-2","article-title":"Seroadaptation among men who have sex with men: emerging research themes","volume":"10","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key20180212135453_r26","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/cir696","article-title":"Sexually transmitted diseases in men who have sex with men","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"key20180212135453_r27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3928\/00989134-20130918-01","article-title":"Sexually transmitted infections and older adults","volume":"39","year":"2013","journal-title":"J Gerontol Nurs"},{"issue":"1","key":"key20180212135453_r28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/QCO.0b013e32835c2173","article-title":"Sexually transmitted infections in older populations","volume":"26","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"17","key":"key20180212135453_r29","first-page":"187","article-title":"Suboptimal reporting of notifiable diseases in Canadian emergency departments: a survey of emergency physician knowledge, practices, and perceived barriers","volume":"32","year":"2006","journal-title":"Can Commun Dis Rep"},{"issue":"9","key":"key20180212135453_r30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/aje\/155.9.866","article-title":"Completeness of notifiable infectious disease reporting in the United States: an analytical literature review","volume":"155","year":"2002","journal-title":"Am J Epidemiol"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2018-44\/issue-2-february-1-2018\/ccdrv44i02a01-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T21:13:26Z","timestamp":1570742006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2018-44\/issue-2-february-1-2018\/ccdrv44i02a01-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v44i02a01","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}